CASR and Hypocalcemia: Screening patients through CaSR genotyping can achieve accurate selection of therapeutic drugs (such as calcium channel blockers, RAS inhibitors, calcium-sensitive receptor modulators), and predict the risk of adverse reactions (such as hypocalcemia and hyperkalemia), significantly improving the safety and efficacy of the treatment.